NOVEL GLP-1 RECEPTOR AGONISTS WITH CHOLESTEROL EFFLUX ACTIVITY

The present invention provides novel glucagon-like protein-1(GLP-1) receptor agonist compounds that promote cholesterol efflux. The present invention also provides compositions comprising the novel glucagon-like protein-1(GLP-1) receptor agonist compounds, and relates to the use of said compounds in...

Full description

Saved in:
Bibliographic Details
Main Authors KODRA JANOS TIBOR, LAU JESPER, RASMUSSEN SALKA ELBOL, ROLIN BIDDA CHARLOTTE, THOGERSEN HENNING, TORNOE CHRISTIAN WENZEL
Format Patent
LanguageEnglish
Published 07.10.2015
Subjects
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Online AccessGet full text

Cover

More Information
Summary:The present invention provides novel glucagon-like protein-1(GLP-1) receptor agonist compounds that promote cholesterol efflux. The present invention also provides compositions comprising the novel glucagon-like protein-1(GLP-1) receptor agonist compounds, and relates to the use of said compounds in therapy, to methods of treatment comprising administration of said compounds to patients, and to the use of said compounds in the manufacture of medicaments.
Bibliography:Application Number: CN201380067034